These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18953792)

  • 1. [The family practitioner's dilemma: the total serum cholesterol between 5 and 8 mmol/l].
    Wahlberg G
    Lakartidningen; 2008 Oct 1-7; 105(40):2788-9. PubMed ID: 18953792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nuanced view on cholesterol. New guidelines on prevention of cardiovascular diseases].
    Olsson AG
    Lakartidningen; 1993 Jul; 90(28-29):2525-7. PubMed ID: 8326795
    [No Abstract]   [Full Text] [Related]  

  • 3. [HeartScore, PC-based cardiovascular risk assessment. A cooperation between general practitioners and cardiologists].
    Perk J; Thomsen T
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1893-5. PubMed ID: 16044769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension in Finnish general practice seems unsatisfactory despite evidence-based guidelines.
    Varis J; Savola H; Vesalainen R; Kantola I
    Blood Press; 2009; 18(1-2):62-7. PubMed ID: 19353413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audit on cardiovascular disease preventive care in general practice.
    Afifi M
    Singapore Med J; 2008 Nov; 49(11):956-7; author reply 957-8. PubMed ID: 19037566
    [No Abstract]   [Full Text] [Related]  

  • 7. Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50.
    Rosengren A; Eriksson H; Hansson PO; Svärdsudd K; Wilhelmsen L; Johansson S; Welin C; Welin L
    J Intern Med; 2009 Sep; 266(3):268-76. PubMed ID: 19486264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk: who should we treat, and how much should we stratify?
    Patel A
    Heart; 2009 May; 95(10):783-4. PubMed ID: 19131441
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of low HDL cholesterol, and relationship between serum HDL and cardiovascular disease in elderly Spanish population: the PREV-ICTUS study.
    Cea-Calvo L; Lozano JV; Fernández-Pérez C; Llisterri JL; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
    Int J Clin Pract; 2009 Jan; 63(1):71-81. PubMed ID: 19125995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM; Bastiaans K; Keogh JB
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The general practitioner's role in the prevention of coronary heart disease.
    Fowler G
    Practitioner; 1986 Oct; 230(1420):859-62, 864. PubMed ID: 3658893
    [No Abstract]   [Full Text] [Related]  

  • 14. [Global risk and objectives in cardiovascular diseases].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():1-10. PubMed ID: 19404044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring of cardiovascular risk factors in patients with diabetes type 2].
    Petrlová B; Rosolová H; Simon J; Sefrna F; Sifalda P; Sípová I
    Vnitr Lek; 2009 Sep; 55(9):812-8. PubMed ID: 19785382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is my risk of developing cardiovascular disease?
    Graham IM; Cooney MT; Dudina A; Squarta S
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S2-7. PubMed ID: 19675432
    [No Abstract]   [Full Text] [Related]  

  • 17. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
    Langsted A; Freiberg JJ; Nordestgaard BG
    Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Turkish Cardiovascular Risk Platform and United States National Cholesterol Education Program Adult Treatment Panel III definitions of the metabolic syndrome in Turkish adults.
    Can AS; Ozbayrakçi S; Palaoğlu KE; Bersot TP
    J Cardiometab Syndr; 2009; 4(1):26-32. PubMed ID: 19245513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk in psoriatic arthritis].
    Badokin VV; Ianysheva AV; Aleksandrova EN; Mach ES; Popkova TV
    Ter Arkh; 2009; 81(6):41-7. PubMed ID: 19663192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.